Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to “Chiron Real Estate Inc.” Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the “NYSE”) under the new name, “Chiron Real Estate Inc.,” and ticker symbol “XRN.” “After spending the last six months evaluating and redefining our str.

Business Wire • Feb 3, 2026

Global Medical REIT Reports Tax Treatment of 2025 Dividends

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to refle.

Business Wire • Jan 27, 2026

Global Medical REIT Inc. Announces Henry Cole Stepping Down from its Board of Directors

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Henry Cole has notified the Board of Directors (the “Board”) that he plans to step down as a member of the Board at the end of his current term. Henry Cole's Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company's inception and has served at different points throughout his term as the Board's Lead Independent Director,.

Business Wire • Jan 26, 2026

Global Medical REIT: Buy This 9% Yield While The Market Ignores Value

Global Medical REIT offers a compelling value proposition, with an 8.9% dividend yield and a forward P/FFO of 8.3. GMRE's diversified healthcare portfolio, 95%+ occupancy, and 2.1% annual rent escalators support steady cash flows and modest growth. Management's proactive debt restructuring extends maturities, mitigating refinancing risk.

Seeking Alpha • Jan 6, 2026

Global Medical REIT: Attractively Priced Preferred Shares

Global Medical REIT offers a diversified, granular healthcare property portfolio with 95.2% occupancy and an average remaining lease term of 5.3 years. GMRE has proactively extended and staggered its debt maturities, raised $50M in Series B preferred equity, and improved balance sheet flexibility. The Series A Preferred Shares yield 7.7%, are past call, and are unlikely to be redeemed soon given current rates and refinancing costs.

Seeking Alpha • Jan 6, 2026

1 REIT To Sell And 1 Better REIT To Buy

Active investors have an advantage in the REIT sector. Individual REITs often get mispriced, resulting in opportunities to earn alpha-rich returns. We highlight a clear example of that.

Seeking Alpha • Jan 5, 2026

Global Medical REIT: Time To Buy As The Need For Outpatient Care Could Grow

Global Medical REIT is rated a buy, driven by strong AFFO growth, robust dividend coverage, and sector tailwinds. GMRE redeploys capital into higher cap-rate assets, maintains low tenant concentration risk, and benefits from geographic diversification including presence in high-growth regions like Texas and Florida. Despite elevated leverage (D/E 1.50), GMRE's forward P/FFO of 8.6 is 35% below sector average, suggesting undervaluation.

Seeking Alpha • Dec 16, 2025

Market Bubble? Buy These Defensive Dividends Instead, Earn +7.5% Income

We are in the midst of the biggest retail sales period of the year. Yet, investors are skeptical about bargains in the stock market. Buy a bigger income stream at cheaper prices. We discuss our top defensive picks with up to 8% yields.

Seeking Alpha • Dec 5, 2025

Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ.

Business Wire • Dec 4, 2025

GMRE.PR.B: An 8.00% Preferred Stock IPO From Global Medical REIT

Global Medical REIT Inc. has launched its 8.00% Series B Cumulative Redeemable Preferred Stock GMRE.PR.B, targeting high-yield seeking investors. GMRE-B offers a high yield but is considered highly speculative, with no credit rating and a risk profile similar to Single-B rated debt. Recent red flags for GMRE include a reverse stock split, a dividend cut, and a debt-heavy capital structure, warranting extra caution for investors.

Seeking Alpha • Dec 1, 2025